SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-066417
Filing Date
2021-05-14
Accepted
2021-05-14 08:30:38
Documents
3
Period of Report
2021-05-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2116320d1_8k.htm 8-K 17479
2 EXHIBIT 99.1 tm2116320d1_ex99-1.htm EX-99.1 64770
3 GRAPHIC image_001.jpg GRAPHIC 4071
  Complete submission text file 0001104659-21-066417.txt   89259
Mailing Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830
Business Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830 6096193990
Outlook Therapeutics, Inc. (Filer) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37759 | Film No.: 21922044
SIC: 2836 Biological Products, (No Diagnostic Substances)